AUTHOR=Guo Chunguang , Liu Zaoqu , Cao Can , Zheng Youyang , Lu Taoyuan , Yu Yin , Wang Libo , Liu Long , Liu Shirui , Hua Zhaohui , Han Xinwei , Li Zhen 

TITLE=Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy

JOURNAL=Frontiers in Cell and Developmental Biology

VOLUME=10

YEAR=2022

URL=https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.794608

DOI=10.3389/fcell.2022.794608

ISSN=2296-634X

ABSTRACT=<p><bold>Background:</bold> Ischemic events after carotid endarterectomy (CEA) in carotid artery stenosis patients are unforeseeable and alarming. Therefore, we aimed to establish a novel model to prevent recurrent ischemic events after CEA.</p><p><bold>Methods:</bold> Ninety-eight peripheral blood mononuclear cell samples were collected from carotid artery stenosis patients. Based on weighted gene co-expression network analysis, we performed whole transcriptome correlation analysis and extracted the key module related to ischemic events. The biological functions of the 292 genes in the key module were annotated via GO and KEGG enrichment analysis, and the protein-protein interaction (PPI) network was constructed via the STRING database and Cytoscape software. The enrolled samples were divided into train (<italic>n</italic> = 66), validation (<italic>n</italic> = 28), and total sets (<italic>n</italic> = 94). In the train set, the random forest algorithm was used to identify critical genes for predicting ischemic events after CEA, and further dimension reduction was performed by LASSO logistic regression. A diagnosis model was established in the train set and verified in the validation and total sets. Furthermore, fifty peripheral venous blood samples from patients with carotid stenosis in our hospital were used as an independent cohort to validation the model by RT-qPCR. Meanwhile, GSEA, ssGSEA, CIBERSORT, and MCP-counter were used to enrichment analysis in high- and low-risk groups, which were divided by the median risk score.</p><p><bold>Results:</bold> We established an eight-gene model consisting of <italic>PLSCR1</italic>, <italic>ECRP</italic>, <italic>CASP5</italic>, <italic>SPTSSA</italic>, <italic>MSRB1</italic>, <italic>BCL6</italic>, <italic>FBP1</italic>, and <italic>LST1</italic>. The ROC-AUCs and PR-AUCs of the train, validation, total, and independent cohort were 0.891 and 0.725, 0.826 and 0.364, 0.869 and 0.654, 0.792 and 0.372, respectively. GSEA, ssGSEA, CIBERSORT, and MCP-counter analyses further revealed that high-risk patients presented enhanced immune signatures, which indicated that immunotherapy may improve clinical outcomes in these patients.</p><p><bold>Conclusion:</bold> An eight-gene model with high accuracy for predicting ischemic events after CEA was constructed. This model might be a promising tool to facilitate the clinical management and postoperative surveillance of carotid artery stenosis patients.</p>